Associations between sleep disordered breathing (SDB) and cardiometabolic outcomes have not been examined in highlanders.
We performed nocturnal polygraphy in Peruvian highlanders (3825m). Multi-variable linear regression models examined associations between SDB metrics and hemoglobin, glucose tolerance (hemoglobin A1c (HbA1c), fasting glucose and homeostatic model assessment of β-cell function (HOMA-β) and insulin resistance (HOMA-IR)), blood pressure and lipids, while adjusting for age, sex, body-mass index (BMI) and wake oxygenation.
Participants (n=187, 91 men) were 52 years-old (IQR 45–62), had BMI of 27.0 kg/m2 (24.3–29.5) and 87% (85–88) oxyhemoglobin saturation during wakefulness. In fully adjusted models, worsening nocturnal hypoxemia was associated with hemoglobin elevations in men (p=0.03), independent of wake oxygenation and apnea-hypopnea index (AHI); whereas worsening wake oxygenation was associated with hemoglobin elevations in older women (p=0.02). In contrast, AHI was independently associated with HbA1c elevations (p<0.05). In single-variable models, nocturnal hypoxemia was associated with higher HbA1c, HOMA-IR and HOMA-β (p<0.001, =0.02 and =0.04); whereas AHI was associated with HOMA-IR, systolic blood pressure and triglyceride elevations (p=0.02, =0.01, and <0.01). These associations were not significant in fully adjusted models.
In highlanders, nocturnal hypoxemia and sleep apnea were associated with distinct cardiometabolic outcomes, conferring differential risk for excessive erythrocytosis and glucose intolerance, respectively.